Healthy Volunteers Clinical Trial
Official title:
Long-Term Improvement in Training Effects by Transcranial DC Stimulation
This study will examine whether continuous use of transcranial direct current stimulation
(tDCS) in combination with motor training can lead to long-term improvement in movement
performance beyond what can be achieved with motor training alone.
Healthy normal volunteers 18-80 years of age who are clearly right- or left-handed may be
eligible for this study. Each candidate is screened with a medical history, clinical and
neurological examination, questionnaires to evaluate memory, attention, and handedness and a
brain MRI, if one has not been done by NINDS within 12 months of entering the study. Pregnant
women may not participate.
The study involves 10 sessions (in addition to the screening visit) over 3 months. Sessions
1-5 are completed over 5 consecutive days. Sessions 6-10 are divided over the remaining time.
Participants are randomly assigned to one of three groups: 1) tDCS during motor training; 2)
tDCS after training; or 3) training with sham tDCS. During these sessions, participants
perform a pinch force task (squeezing a small device between the thumb and forefinger) and
visuomotor tasks (using a device to move the cursor on a computer screen to various targets
and holding the cursor in place for 1 second).
During the motor training and performance sessions, participants have the following
procedures.
- TMS measurements: A wire coil is held on the scalp, and a brief electrical current is
passed through the coil, creating a magnetic pulse that stimulates the brain. During the
stimulation, the subject may be asked to tense certain muscles slightly or perform other
simple actions. The stimulation may cause a twitch in muscles of the face, arm, or leg,
and the subject may hear a click and feel a pulling sensation on the skin under the
coil.
- tDCS: Small, wet sponge electrodes are applied to the head - one above the eye and the
other on the back of the head. A small electrical current is passed between them. The
subject may feel an itching or tingling sensation under the electrodes or see light
flashes. Some sessions are done with sham tDCS.
- Surface electromyography: Electrodes are filled with a conductive gel and taped to the
skin over one small hand muscle to measure the electrical activity of muscles.
- Behavioral measurements: Evaluation of learned movement tasks
- Questionnaires to evaluate the subject's attention, fatigue and mood before and after
testing
OBJECTIVES:
Motor practice and use over one session leads to use-dependent plasticity. When practice is
repeated over multiple sessions, motor performance continues improving until a plateau in
performance, the so-called ceiling effect is reached. This issue is particularly important in
neurorehabilitative treatments in which patients usually reach a ceiling effect without
further improvement. Thus, it would be desirable to modify ceiling effects in motor
rehabilitation. The purpose of this protocol is to determine if repeated applications of
TDCS, a form of non-invasive cortical stimulation known to transiently improve performance,
in association with training, could elicit additional improvements in motor performance
beyond the ceiling effect identified during performance of a visuomotor training task.
We will test the hypothesis that anodal TDCS applied over M1 in temporal relation with motor
training will lead to more prominent long-term learning of a visuomotor task relative to sham
stimulation (which would document the ceiling effect) in healthy individuals and chronic
stroke patients and traumatic brain injury (TB1) patients..
STUDY POPULATION:
We plan to study 177 healthy volunteers (part 1) and 60 chronic stroke patients (part 2) and
50 TB1 patients with 50 additional healthy volunteers (part 3). Therefore, an overall
enrollment of 337 participants is planned.
DESIGN:
The study will follow a parallel design. Healthy volunteers (part 1) and stroke patients
(part 2)will be randomly allocated to one of three groups. Each group will receive anodal
TDCS or sham in a fixed time frame related to motor training (during or immediately after
motor training). TB1 patients and healthy volunteers (part 3) will be randomly allocated to
one of two groups. Each group will receive either sham or anodal tDCS during training.
Healthy volunteers and stroke patients will participate in 10 sessions. First, they will
train a visuomotor task (VMT) on 5 consecutive days while receiving sham stimulation (group
3) or TDCS during (group 1), or immediately after (group 2) the training. Performance of the
VMT will be re-evaluated at 30, 60 and 90 days after the first training session.
Traumatic brain injury (TB1) patients and a group of healthy volunteers (part 3) will
participate in 6 sessions. First, they will train a visumomotor task (VMT) on 3 consecutive
days while receiving anodal tDCS or sham stimulation during the training. Performance of the
VMT will be re-evaluated at 30, 60, and 90 days after the first training session.
OUTCOME MEASURES:
Primary outcome measure will be the percentage change (from baseline to day 8 in healthy
volunteers and stroke patients, and from baseline to day 3 in traumatic brain injury) in the
total time necessary to complete 15 correct trials of the visuomotor task.
Secondary outcome will be accuracy (no. of errors) and timing (speed) variability of force
adaptation in the visuomotor task (Celnik, own data), and pinch force at all other time
points, including day 5 as a measure of learning over the training period and 3 months as a
measure for long-term retention. In the patient group the Jebsen Taylor Test will be used to
assess gross motor function. To better understand the mechanisms underlying the proposed
behavioral gains, we will use single- and paired pulse transcranial magnetic stimulation
(TMS) to identify corticomotor excitability changes. Furthermore the volunteers will answer
several questionnaires to evaluate fatigue and mood (PANAS) and perform short
neuropsychological control task to control for changes in attention and memory function.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
| Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
| Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
| Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
| Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
| Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
| Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
| Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
| Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
| Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
| Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
| Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
| Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
| Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
| Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
| Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
| Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |